"MONOCLONAL ANTIBODY HBME-1 USEFULNESS IN DIFFERENTIATION OF BENIGN NEOPLASM AND DIFFERENTIATED THYROID CARCINOMA" - M. Mokhtari,; M. Sadeghi,; A. Talebi, (Acta Medica Iranica)